Dolutegravir potentiates platelet activation by a calcium-dependent, ionophore-like mechanism

Madzime, Morris; Theron, Annette J.; Anderson, Ronald; Tintinger, Gregory; Steel, Helen C.; Meyer, Pieter Willem Adriaan; Nel, Jan Gert; Feldman, Charles; Rossouw, Theresa M.

dc.contributor.author	Madzime, Morris
dc.contributor.author	Theron, Annette J.
dc.contributor.author	Anderson, Ronald
dc.contributor.author	Tintinger, Gregory
dc.contributor.author	Steel, Helen C.
dc.contributor.author	Meyer, Pieter Willem Adriaan
dc.contributor.author	Nel, Jan Gert
dc.contributor.author	Feldman, Charles
dc.contributor.author	Rossouw, Theresa M.
dc.date.accessioned	2023-02-23T09:32:32Z
dc.date.available	2023-02-23T09:32:32Z
dc.date.issued	2022
dc.description.abstract	Please read abstract in the article.	en_US
dc.description.department	Haematology	en_US
dc.description.department	Immunology	en_US
dc.description.department	Internal Medicine	en_US
dc.description.librarian	hj2023	en_US
dc.description.sponsorship	The National Health Laboratory Research Trust of South Africa and the National Research Foundation of South Africa.	en_US
dc.description.uri	https://www.tandfonline.com/loi/iimt20	en_US
dc.identifier.citation	Morris Madzime, Annette J. Theron, Ronald Anderson, Gregory R. Tintinger, Helen C. Steel, Pieter W. A. Meyer, Jan G. Nel, Charles Feldman & Theresa M. Rossouw (2022) Dolutegravir potentiates platelet activation by a calcium-dependent, ionophore-like mechanism, Journal of Immunotoxicology, 19:1, 117-124, DOI: 10.1080/1547691X.2022.2142705.	en_US
dc.identifier.issn	1547-691X (print)
dc.identifier.issn	1547-6901 (online)
dc.identifier.issn	10.1080/1547691X.2022.2142705
dc.identifier.uri	https://repository.up.ac.za/handle/2263/89791
dc.language.iso	en	en_US
dc.publisher	Taylor and Francis	en_US
dc.rights	© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/).	en_US
dc.subject	Dolutegravir (DTG)	en_US
dc.subject	Platelets	en_US
dc.subject	Calcium fluxes	en_US
dc.subject	Neutrophil: platelet aggregates	en_US
dc.subject	CD62P	en_US
dc.subject.other	Health sciences articles SDG-03
dc.subject.other	SDG-03: Good health and well-being
dc.subject.other	Health sciences articles SDG-04
dc.subject.other	SDG-04: Quality education
dc.subject.other	Health sciences articles SDG-09
dc.subject.other	SDG-09: Industry, innovation and infrastructure
dc.title	Dolutegravir potentiates platelet activation by a calcium-dependent, ionophore-like mechanism	en_US
dc.type	Article	en_US